Distribution of intraventricularly administered antiamyloid-beta peptide (Aβ) antibody in the mouse brain

Journal of Neuroscience Research

Volumn 66, Issue 2, 2001, Pages 231-235

  Chauhan, Neelima B ^a   Siegel, George J ^a,b,e   Lichtor, Terry ^a,c,d  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d RUSH MEDICAL COLLEGE   (United States)

^e HINES VA HOSPITAL   (United States)

Author keywords

A ; Antibody clearance; Antibody trafficking; HRP labeled antibody; Intracerebral injection; Trypan blue

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; EPITOPE; HORSERADISH PEROXIDASE; PEPTIDE ANTIBODY; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; BRAIN MAPPING; BRAIN VENTRICLE; CEREBELLUM CORTEX; CONTROLLED STUDY; FRONTAL CORTEX; HIPPOCAMPUS; MICROVASCULATURE; MOUSE; NEUROTOXICITY; NONHUMAN; PARENCHYMA; PARIETAL LOBE; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN CHEMISTRY; COLORING AGENTS; FRONTAL LOBE; HIPPOCAMPUS; HORSERADISH PEROXIDASE; IMMUNIZATION, PASSIVE; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED C57BL; MICROCIRCULATION; PARIETAL LOBE; TRYPAN BLUE;

EID: 0035888264     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.1215     Document Type: Article

References (31)

1. The effect of continuous intraventricular infusion of L1 and NCAM antibodies on spatial learning in rats
2. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer's disease
3. Intracerebroventricular injection of anti-Fas activates the hypothalamus-pituitary-adrenal axis and induces peripheral interleukin-6 and serum amyloid A in mice: Comparison with other ligands of the tumor necrosis factor/nerve growth factor receptor superfamily
4. Pharmacokinetics of IgG and IgM antiganglioside antibodies in rats and monkeys after intrathecal administration
5. Treatment of neoplastic meningeal xenografts by intraventricular administration of an antiganglioside monoclonal antibody, 3F8
6. 192 IgG-saporin: I. Specific lethality for cholinergic neurons in the basal forebrain of the rat
7. 192 IgG-saporin. 2. Neuropathology in the rat brain
8. Radioimmunotherapy of intracerebral human glioma xenografts with I-131-labeled F(ab′)2 fragments of monoclonal antibody Mel-14
9. Diffuse plaques contain C-terminal A beta 42 and not Abeta 40: Evidence from cats and dogs
10. Radiotoxicity of h-R3 monoclonal antibody labeled with 188Re administered intracerebrally in rats
11. Regulation of mu binding sites after chronic administration of antibodies directed against specific anti-opiate peptides
12. Pharmacokinetics and acute toxicity of intraventricular [I]131-monoclonal antibody targeting disialoganglioside in non-human primates
13. Intraventricular immunotoxin therapy for leptomeningeal neoplasia
14. Selective immunolesioning of the basal forebrain cholinergic system disrupts short-term memory in rats
15. Direct stereotaxic intracerebral injection of monoclonal antibodies and their fragments: A potential approach to brain tumor immunotherapy
16. Behavioral and neurochemical alterations following intracerebroventricular administration of anti-serotonin antibodies in adult Balb/c mice
17. Dissociable effects of AMPA-induced lesions of the vertical limb diagonal band of Broca on performance of the 5-choice serial reaction time task and on acquisition of a conditional visual discrimination
18. Pharmacokinetics and dose estimates following intrathecal administration of [I]131-monoclonal antibodies for the treatment of central nervous system malignancies
19. Regulation of gonadal and somatotropic axis by chronic intraventricular infusion of insulin-like growth factor 1 antibody at the initiation of puberty in male rats
20. 192IgG-saporin-induced immunotoxic lesions of cholinergic basal forebrain system differentially affect glutamatergic and GABAergic markers in cortical rat brain regions
21. Intracerebroventricular infusion of CHO5, a rat monoclonal antibody directed against mouse low-affinity nerve growth factor receptor (p75NTR), specifically labels basal forebrain cholinergic neurons in mouse brain
22. Immunolesion by 192IgG-saporin of rat basal forebrain cholinergic system: A useful tool to produce cortical cholinergic dysfunction
23. Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer's beta amyloid peptide
24. Immunohistological study of senile brains by using a monoclonal antibody recognizing beta amyloid precursor protein: Significance of granular deposits in relation with senile plaques
25. Intracerebroventricular passive immunization. II. Intracerebroventricular infusion of neuropeptide antisera can inhibit neuropeptide signaling in peripheral tissues
26. Central administration of antiserum to vasoactive intestinal peptide delays and reduces luteinizing hormone and prolactin surges in ovariectomized, estrogen-treated rats
27. Intraventricular administration of antibodies to nerve growth factor retards kindling and blocks mossy fiber sprouting in adult rats
28. 192 Immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells
29. Stability, clearance, and disposition of intraventricularly administered oligonucleotides: Implications for therapeutic application within the central nervous system
30. Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier